Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posterior Cellular Bonegraft Options for Single Level Lumbar Spinal Fusion
NCT07187362Phase 3Completed
- Sponsor
- Midwest Spine & Brain Institute
- Start
- Oct 2015
- Primary completion
- Aug 2019
- Modality
- Adult Stem Cells, Tissue Cells
01
Overview
Phase 3, randomised, double-blind trial of Trinity Elite, CELZ-201 and NuCel in degenerative disc disease (DDD), sponsored by Midwest Spine & Brain Institute. Started Oct 2015; status: completed.
02
Drugs
Trinity EliteCELZ-201NuCel
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT07187362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07187362.